Venture Life Group plc (FRA:17V)
Germany · Delayed Price · Currency is EUR | Market Cap | 95.98M +18.4% |
| Revenue (ttm) | 40.69M +32.6% |
| Net Income | 2.78M |
| EPS | 0.02 |
| Shares Out | n/a |
| PE Ratio | 34.62 |
| Forward PE | 7.40 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,316 |
| Open | 0.7700 |
| Previous Close | 0.7850 |
| Day's Range | 0.7700 - 0.7850 |
| 52-Week Range | 0.5750 - 0.8200 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 1, 2026 |
About Venture Life Group
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers women’s healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. It also provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; and Glucogel for the treatment of hypoglycaemia. In addition, the company offers ENT care products... [Read more]
Financial Performance
In fiscal year 2026, Venture Life Group's revenue was 35.27 million, an increase of 0.30% compared to the previous year's 35.17 million. Earnings were 2.41 million, a decrease of -60.67%.
Financial numbers in GBP Financial StatementsNews
Venture Life Group Transcript: Transition period
Revenue rose 16% like-for-like over 17 months, with power-brand momentum and a simplified consumer-health portfolio. Guidance is £55m revenue to May 2027, while U.S. expansion and selective M&A underpin longer-term growth.
Venture Life Group Annual report: Transition period
Venture Life Group has published an annual report on October 1, 2026.
Venture Life Group Annual report: Transition period
Venture Life Group has published an annual report on October 1, 2026.
Venture Life Group Slides: Transition period
Venture Life Group has posted slides in relation to its latest quarterly earnings report, which was published on October 1, 2026.
Venture Life Group Earnings release: Trading update
Venture Life Group released its earnings on June 30, 2026, summarizing the period's financial results.
Venture Life Group Earnings Call Transcript: H2 2025
Major divestments and a shift to a brand-focused model drove 11% organic and 32% reported revenue growth, with strong cash generation and double-digit growth continuing into 2026. Power brands excelled, especially in women's and men's health, while digital transformation and innovation underpin future expansion.
Venture Life Group Annual report: H2 2025
Venture Life Group has published its H2 2025 annual report on April 2, 2026.
Venture Life Group Slides: H2 2025
Venture Life Group has posted slides in relation to its H2 2025 quarterly earnings report, which was published on April 2, 2026.
Venture Life Group Earnings release: H2 2025
Venture Life Group released its H2 2025 earnings on January 26, 2026, summarizing the period's financial results.